Your browser doesn't support javascript.
loading
Safety, efficacy, and tolerability of immune checkpoint inhibitors in the treatment of hepatocellular carcinoma.
Brown, Zachary J; Gregory, Stephanie; Hewitt, D Brock; Iacono, Stephen; Choe, Jennie; Labiner, Hanna E; Pawlik, Timothy M.
Afiliação
  • Brown ZJ; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Gregory S; Rutgers Robert Wood Johnson Medical School, Department of Surgery, New Brunswick, NJ, USA.
  • Hewitt DB; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Iacono S; Rutgers Robert Wood Johnson Medical School, Department of Surgery, New Brunswick, NJ, USA.
  • Choe J; Rutgers Robert Wood Johnson Medical School, Department of Surgery, New Brunswick, NJ, USA.
  • Labiner HE; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Rutgers Robert Wood Johnson Medical School, Department of Surgery, New Brunswick, NJ, USA.
  • Pawlik TM; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. Electronic address: Tim.pawlik@osumc.edu.
Surg Oncol ; 42: 101748, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35395582
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos